In the study by Ramsey et al., the knockout of TP63 in mice with advanced SCC led to tumor regression, indicating that TP63 may have an oncogenic role under these conditions, similar to LUAD/LUSC [173]. The gene discussed is TP63; the disease is neoplasm.